Abstract

A significantly increased level of the reactive oxygen species (ROS) scavenger glutathione (GSH) has been identified as a hallmark of renal cell carcinoma (RCC). The proposed mechanism for increased GSH levels is to counteract damaging ROS to sustain the viability and growth of the malignancy. Here, we review the current knowledge about the three main RCC subtypes, namely clear cell RCC (ccRCC), papillary RCC (pRCC), and chromophobe RCC (chRCC), at the genetic, transcript, protein, and metabolite level and highlight their mutual influence on GSH metabolism. A further discussion addresses the question of how the manipulation of GSH levels can be exploited as a potential treatment strategy for RCC.

Highlights

  • Increased reactive oxygen species (ROS) levels, including the superoxide anion, hydrogen peroxide, and hydroxyl radical, have been reported in many different cancer types

  • We review the current knowledge about the three main renal cell carcinoma (RCC) subtypes, namely clear cell RCC, papillary RCC, and chromophobe RCC, at the genetic, transcript, protein, and metabolite level and highlight their mutual influence on GSH metabolism

  • The de novo biosynthesis of GSH involves two ATP-dependent enzymatic reactions: The first step is catalyzed by glutamate cysteine ligase (GCL), which ligates the amino group of cysteine to the γ-carboxylate of glutamic acid to form the dipeptide γ-glutamyl cysteine

Read more

Summary

Introduction

Increased reactive oxygen species (ROS) levels, including the superoxide anion, hydrogen peroxide, and hydroxyl radical, have been reported in many different cancer types. Glutathione (GSH), a tripeptide thiol antioxidant composed of the amino acids glutamic acid, cysteine, and glycine [2], is the main ROS scavenger in cells. Massive ROS accumulations can limit by causing severe damage of biomolecules, canwhich lead to cell death [13].toAs cancer growth by oxidative causing severe oxidative damage ofwhich biomolecules, can lead cella consequence, cancer cells are required to deliberately balance the levels of and antioxidants Cancer cells are required to deliberately balance the levels of ROS and GSH) to maintain redox homeostasis, which sustains viabilitywhich and growth. We ROS will focus on the role of the ROS scavenger GSH in RCC and discuss possible supplementation with inhibitors strategies that can potentially exploit of scavenger.

Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Papillary Renal Cell Carcinoma
Chromophobe Renal Cell Carcinoma
Precursor Amino Acid Availability for GSH de novo Synthesis
Fumarate Hydratase Mutations and GSH in Type II pRCC
Glutathione Salvage Pathway in chRCC
Therapeutic Strategies to Exploit Increased GSH Levels in RCC
Glutaminase 1 Inhibitor
The Glutamate–Cysteine Ligase Inhibitor Buthionine Sulfoximine
Inhibition of Deubiquitinating Enzymes Initiates Proteotoxicity
The Role of GSH Metabolism in the Immune Microenvironment of the Tumor
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call